SCOR (EPA:SCR) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

PRESS RELEASE

published on 07/15/2024 at 21:27, 4 months 5 days ago

SCOR provides an update on its Q2 2024 and FY 2024 results
SCOR provides updates on Q2 2024 and FY 2024 results, reflecting significant adjustments in L&H insurance service result, pre-tax CSM, and Group EV. Details to be disclosed in Q3 and Q4 2024

Q2 2024 SCOR FY 2024 L&H Insurance Service Group EV
BRIEF

published on 06/06/2024 at 19:05, 5 months 14 days ago

SCOR Announces Share Capital and Voting Rights as of May 31, 2024

Share Capital Voting Rights Reinsurance Financial Disclosure SCOR
PRESS RELEASE

published on 06/06/2024 at 19:00, 5 months 14 days ago

Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers
SCOR, a global reinsurer, discloses total shares and voting rights as of May 31, 2024. The company generated EUR 19.4 billion premiums in 2023 from 160 countries

Voting Rights Total Shares SCOR Global Reinsurer EUR 19.4 Billion
BRIEF

published on 05/17/2024 at 07:35, 6 months 4 days ago

SCOR announces solid results for the first quarter of 2024

Reinsurance Insurance Return On Equity SCOR Quarterly Finances
PRESS RELEASE

published on 05/17/2024 at 07:30, 6 months 4 days ago

First quarter 2024 results: SCOR starts 2024 with a strong first three-months net income of EUR 196 million
SCOR reports strong first quarter 2024 results with a net income of EUR 196 million. Group's solvency ratio reaches 215%. CEO expresses optimism for the year ahead

Financial Results Q1 2024 SCOR Solvency Ratio Insurance Revenue
BRIEF

published on 04/29/2024 at 17:54, 6 months 21 days ago

Claire McDonald, New Managing Director of SCOR Business Solutions

Insurance Management Executive Director SCOR Claire McDonald
PRESS RELEASE

published on 04/29/2024 at 17:49, 6 months 21 days ago

Claire McDonald is appointed CEO of SCOR Business Solutions and member of SCOR’s Executive Committee
Claire McDonald appointed CEO of SCOR Business Solutions & member of SCOR's Executive Committee. Strategic leadership change effective on 1 September 2024 in London

Executive Committee CEO Appointment Leadership Change Claire McDonald SCOR Business Solutions

Accesswire

Published on 11/21/2024 at 13:30, 33 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 33 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 48 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 27 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 48 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 56 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 3 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 5 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 43 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 18 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 18 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE